Review
Accepted on 24 Jul 2025
Naringenin as a neurotherapeutic agent in Alzheimer's disease: Epigenetic signatures, gut microbiota alterations, and molecular neuroprotection
in Alzheimer's Disease and Related Dementias
Review
Accepted on 24 Jul 2025
in Alzheimer's Disease and Related Dementias
Review
Accepted on 24 Jul 2025
in Stroke
Original Research
Accepted on 24 Jul 2025
in Alzheimer's Disease and Related Dementias
Original Research
Accepted on 24 Jul 2025
in Molecular Innate Immunity
Case Report
Accepted on 24 Jul 2025
in Genetics of Common and Rare Diseases
Case Report
Accepted on 24 Jul 2025
in Neurosurgery
Original Research
Accepted on 24 Jul 2025
in Stroke
Clinical Trial
Accepted on 24 Jul 2025
in Pharmacogenetics and Pharmacogenomics
Original Research
Accepted on 24 Jul 2025
in Ethnopharmacology
Review
Accepted on 24 Jul 2025
in Cellular Neurophysiology
Original Research
Accepted on 24 Jul 2025
in Process and Energy Systems Engineering
Original Research
Accepted on 24 Jul 2025
in Neuro-Otology
Original Research
Accepted on 24 Jul 2025
in Drugs Outcomes Research and Policies
Original Research
Accepted on 24 Jul 2025
in Ethnopharmacology
Original Research
Accepted on 24 Jul 2025
in Veterinary Emergency and Critical Care Medicine
Original Research
Accepted on 24 Jul 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders